eLetters

133 e-Letters

published between 2014 and 2017

  • Re:Outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy
    Giuseppe Querques

    We thank Drs Calugaru M. and Calugaru D. for their interest in our article,1 and we welcome this opportunity to address their concerns. The purpose of our study was to investigate the outcomes of intravitreal antivascular endothelial growth factor (VEGF) therapy in eyes with both neovascular age-related macular degeneration (AMD) and diabetic retinopathy (DR) as higher levels of VEGF due to concomitant DR in eyes with a...

    Show More
  • Outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy
    Mihai Calugaru

    Outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy Dan Calugaru, Mihai Calugaru Department of Ophthalmology, Univ of Medicine Cluj-Napoca/Romania

    Re: Outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy. Bandello et al. Br J Ophthalmol 2016; http:+/dx. do...

    Show More
  • Comment on: Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole
    Jagat Ram

    eLetter Comment on: Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole Parul Chawla Gupta, MS; Jagat Ram, MS, FAMS Department of Ophthalmology Post Graduate Institute of Medical Education and Research, Chandigarh, India, 160012 Corresponding author Dr. Jagat Ram, MS, FAMS Professor and Head Department of Ophthalmology Post Graduate...

    Show More
  • Comment on: The impact of donor age and endothelial cell density on graft survival following penetrating keratoplasty
    Jagat Ram

    eLetter Comment on: The impact of donor age and endothelial cell density on graft survival following penetrating keratoplasty Parul Chawla Gupta, MS; Jagat Ram, MS, FAMS Department of Ophthalmology Post Graduate Institute of Medical Education and Research, Chandigarh, India, 160012 Corresponding author Dr. Jagat Ram, MS, FAMS Professor and Head Department of Ophthalmology Post Graduate Institute of Medical Education and Re...

    Show More
  • Intravitreal bevacizumab for diabetic macular edema: 5-year results of the Pan-American collaborative retina study group
    Mihai Calugaru

    Intravitreal bevacizumab for diabetic macular oedema: 5-year results of the Pan-American collaborative retina study group. Dan Calugaru, Mihai Calugaru Department of Ophthalmology, Univ of Medicine Cluj-Napoca/Romania

    Re: Intravitreal bevacizamab for diabetic macular oedema: 5-year results of the Pan-American collaborative retina study group. Arevalo et al. Br J Ophthalmol published online on February 24, 2016...

    Show More
  • Comment on: Morphological features in anterior scleral inflammation using swept-source optical coherence tomography with multiple B-scan averaging.
    Andreas Ebneter

    Dear Editor,

    I read with interest the article by Kuroda et al.[1] The authors explored new possibilities of anterior segment imaging using a posterior segment swept-source optical coherence tomography device without noteworthy modifications. Interestingly, it was possible to obtain high- resolution images of the conjunctiva, episclera, and the sclera near the limbus that seemingly allow unequivocal identificati...

    Show More
  • Re:Comment on: Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trials
    Ronald P. Danis

    Dear Editor, We thank Drs Gupta and Ram for their interest in our recent paper on the anatomical effects of dexamethasone intravitreal implant (DEX implant) in eyes with diabetic macular oedema [1] and appreciate the opportunity to respond to their comments. Their letter highlights various patient- and treatment-related factors that potentially might have influenced the retinal findings described in our analysis. We pro...

    Show More
  • Re:Diurnal variations in luminal and stromal areas of choroid in normal eyes
    Takamasa Kinoshita

    Dear Editor,

    We thank Drs. Uzun and Pehlivan for their interest and comments to our article.[1] We compared and correlated the central choroidal thickness to the different choridal parameters at different times between 9:00 h and 18:00 h. We compared the findings between 09:00 h and 12:00 h, 09:00 h and 15:00 h, 09:00 h and 18:00 h, 12:00 h and 15:00 h, 12:00 h and 18:00 h, and 15:00 h and 18:00 h. There were...

    Show More
  • Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration
    Mihai Calugaru

    Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration Dan C?lug?ru, Mihai C?lug?ru Department of Ophthalmology, Univ of Medicine Cluj-Napoca/Romania

    Re: Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration. Barthelmes et al. Br J Ophthalmol published online on March 18, 2016;doi:10.1136/bjophthalmol- 20...

    Show More
  • Diurnal variations in luminal and stromal areas of choroid in normal eyes
    Salih Uzun

    Dear Editor, We have read and reviewed the article entitled as "Diurnal variations in luminal and stromal areas of choroid in normal eyes'' by Kinoshita et al. with great interest [1]. The authors analyzed systemic blood pressure, heart rate, intraocular pressure, central choroidal thickness (CCT), total cross-sectional choroidal area, the luminal areas, stromal areas and the ratio of luminal area to total choroidal area...

    Show More

Pages